WHO vaccine-preventable diseases: monitoring system. 2013 global summary

Last updated 20-Octl-2013 (data as of 16-Oct-2013)
Next overall update June 2014
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 6'5301 Infant (under 12 months) mortality rate: 142
GDP / capita (US$): 11'1461 Child (under 5 years) mortality rate: 162

Population data in thousands3

  2012  2011  2010  2009  2008  2000  1990  1980 
Total population 181  179  177  175  173  157  138  118 
Births
Surviving infants
Pop. less than 5 years 14  14  14  14  14  16  18  17 
Pop. less than 15 years 44  44  45  45  46  51  50  52 
Female 15-49 years 49  49  49  48  48  41  33  26 

Number of reported case

(Click for retrospective incidence data for Saint Lucia)
Diphtheria
Japanese encephalitis
Measles 30  35 
Mumps 73 
Pertussis 19 
Polio*
Rubella
Rubella (CRS)
Tetanus (neonatal)
Tetanus (total)
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV);"
"it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Saint Lucia)
Vaccine year result method % card seen                                                
BCG          99*  99*  97  97  100  91  94  27 
DTP1          99*  99*  98  99  99  76 
DTP3          98  99  97  95  96  70  89  56 
HepB_BD         
HepB3          98  99  97  95  96 
Hib3          98  99  97  95  96 
JapEnc         
MCV          99*  91  95  99*  100  88  82 
MCV2          80  72  74  63  22  89 
PCV1         
PCV3         
Pol3          98  99  97  95  96  70  90  58 
Rota1         
Rota_last         
Rubella1          99*  91  95  99*  100 
TT2plus         
PAB         
VAD1         
YFV         
  ° indicates that more than 1 survey occurred that year

  Next update: July 2014

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Saint Lucia)
BCG 99  99  97  97  99  91  94  27 
DTP1 99  99  98  99  99  76  96  79 
DTP3 98  99  97  95  96  70  89  56 
HepB3 98  99  97  95  96 
Hib3 98  99  97  95  96 
MCV 99  91  95  99  99  88  82 
PCV3
Pol3 98  99  97  95  96  70  90  58 
Rota_last

Number of districts in the country Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 67
From 80 to 89% 33
From 50 to 79% 0
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2012 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG 6 weeks; Yes
DT 4-5 years; Yes
DTwP 18 months; Yes
DTwPHibHep 3, 5, 7 months; Yes
HIB 3, 5, 7 months; at risk
HepB 3, 5, 7 months; and at risk adolescents and adults
IPV 3, 5, 7, 18 months; 5, 11 years; Yes immunocompromised
Influenza + 10 years; Yes high risk
MMR 1, 4-5, 11 years; Yes
OPV 3, 5, 7, 18 months; 5, 11 years; Yes
Td 11 years; Yes
Varicella + 1 year; Yes at risk
YF + 1 year; Yes Travelers

Immunizaton indicators

Indicator Expected answer 2012  2011  2010  2009  2008  2007  2006 

Planning and management

Multi-year plan (MYP) for immunization Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2013-2014  2012-2013  2011-2012  2010-2011  2009-2010  2006-2010  2005-2015 
Nº of districts with microplans that include activities to raise immunization coverage number 36 

National Immunization Advisory Mechanism

Does the country have a standing technical advisory group on immunization? Yes/No/NR No  No  No         

System performance

Total number of districts in country number
Nº districts with DTP3 coverage >=80% number  
% of districts with DTP3 coverage >=80% From 0 to 100% 100  89  78  67  89  100   
Nº districts with measles (MCV1) coverage >=95% number    
% of districts with MCV1 coverage >=95% From 0 to 100% 33  22  33  33  56     

Safety

Monitoring of Adverse Events Following Immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
Does your country have a vaccine adverse events review committee? Yes/No/NR/ND No  No  No         

Finance

Percentage of routine vaccines funded by Government From 0 to 100%   100  100  100  100  100  100 

Maternal and neonatal tetanus (NT) elimination

NT eliminated Yes/No Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Sources

Unless otherwise specified, data provided by Member States through WHO-UNICEF Joint Reporting Form and WHO Regional offices.
 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2012, data for 2011
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.